| Health / Medical Topics |
Tivantinib
An orally bioavailable small molecule inhibitor of c-Met with potential antineoplastic activity. c-Met inhibitor ARQ 197 binds to the c-Met protein and disrupts c-Met signal transduction pathways, which may induce cell death in tumor cells overexpressing c-Met protein or expressing constitutively activated c-Met protein. c-Met protein, the product of the proto-oncogene c-Met, is a receptor tyrosine kinase also known as hepatocyte growth factor receptor (HGFR); this protein is overexpressed or mutated in many tumor cell types and plays key roles in tumor cell proliferation, survival, invasion, and metastasis, and tumor angiogenesis. (NCI Thesaurus)
YOU MAY ALSO LIKE
A study in which the dosage of the intervention is increased by small increments until the desired physiological effect is seen. …
Adjust a condition by a dropwise addition of a solution.
An official descriptive name of a document, e.g. the long name of a study protocol provided by the study sponsor.
Titin (34350 aa, ~3816 kDa) is encoded by the human TTN gene. This protein plays a role in muscle filament structure and…
Concentration of a substance in a solution as determined by the quantitative reaction with added measured volume(s) of a solution of the…
A sunscreen formulated with titanium dioxide and zinc oxide with broad UV spectrum protecting activity. Upon topical application, titanium dioxide and zinc…
